microdose glp-1 What Is Microdosing GLP-1s, and Is It Safe? Microdose GLP-1 Protocol
Description
GLP1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NFB signaling pathways in streptozotocininduced diabetic rats
Declarations Funding None to declare
Van Bloemendaal L, IJzerman RG, Ten Kulve JS, et al
Partly through these actions, GLP-1 receptor agonism was shown to reduce cardiovascular disease (CVD) in people with T2D with previous CVD or at high-risk thereof
6 In addition, users of these medications have reported other unexpected effects such as alopecia, suicidal ideation, and aspiration, which the FDA is now investigating
doi: 10.3233/JAD-190156 10 KellarDCraftS
